National HealthCare SVP counsel sells 2,719 shares

NHC’s Senior VP & General Counsel reported open-market sales of 2,719 common shares and continues to hold several option grants.

Rhea-AI Filing Summary

NATIONAL HEALTHCARE CORP (NHC) reported that Senior VP & General Counsel Josh A. McCreary sold a total of 2,719 shares of common stock on September 10, 2026, in open-market transactions at weighted average prices around $223–$226 per share. No Rule 10b5-1 trading plan is reported. McCreary continues to hold multiple stock option awards covering shares of NHC common stock.

Insider Trade Summary

Net Seller: 2,719 shares

Net Sell 8 txns

Insider McCreary Josh A

Role Senior VP & General Counsel

Sold 2,719 shs ($610K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	571	$222.7342	$127K
Sale	Common Stock F2	789	$223.778	$177K
Sale	Common Stock F3	1,291	$225.087	$291K
Sale	Common Stock F4, F5	68	$225.5863	$15K
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--
holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,979 shares (Direct); Option to Purchase Common Stock — 35,000 contracts (Direct)

Footnotes (5)

1. F1. The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.31 to $223.21, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
2. F2. The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.35 to $224.15, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
3. F3. The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.56 to $225.515, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
4. F4. The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.565 to $225.60, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
5. F5. Total amount of shares beneficially owned following transactions reported on this form.

Key Figures

Shares sold: 2,719 shares Weighted average sale price 1: $222.7342 per share Weighted average sale price 2: $223.7780 per share +5 more

8 metrics

Shares sold 2,719 shares Total NHC common shares sold by Josh A. McCreary on September 10, 2026

Weighted average sale price 1 $222.7342 per share 571 NHC common shares sold on September 10, 2026

Weighted average sale price 2 $223.7780 per share 789 NHC common shares sold on September 10, 2026

Weighted average sale price 3 $225.0870 per share 1,291 NHC common shares sold on September 10, 2026

Weighted average sale price 4 $225.5863 per share 68 NHC common shares sold on September 10, 2026

Option exercise price $53.94 per share Option to purchase 4,000 NHC shares expiring March 8, 2028

Option exercise price $94.10 per share Option to purchase 8,000 NHC shares expiring March 5, 2029

Largest option position 14,000 underlying shares Option to purchase NHC shares at $157.13 per share, expiring February 23, 2031

Key Terms

weighted average price, beneficially owned, underlying security, exercise price

4 terms

weighted average price financial

"The price reported in Column 4 above is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

beneficially owned financial

"Total amount of shares beneficially owned following transactions reported"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

underlying security financial

"underlying_security_title: "Common Stock" for option holdings"

exercise price financial

"conversion_or_exercise_price values of $53.9400, $94.1000, $90.6200, $157.1300"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did NHC insider Josh A. McCreary report on this Form 4 for NHC?

He reported sales of 2,719 shares of NATIONAL HEALTHCARE CORP common stock on September 10, 2026 in open-market transactions at weighted average prices in the low- to mid-$220s per share, and he continues to hold several stock option grants.

How many NHC shares did Josh A. McCreary sell and at what prices?

He sold 2,719 shares of NHC common stock across four transactions at weighted average prices of $222.7342, $223.7780, $225.0870, and $225.5863 per share, with each average based on multiple trades within specified price ranges.

Were the reported NHC stock sales by McCreary under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as an affirming plan, and the footnotes do not state that these trades were made pursuant to a Rule 10b5-1 trading plan.

What NHC stock options does Josh A. McCreary hold after these transactions?

He is shown holding options to purchase 4,000 shares at $53.94, 8,000 shares at $94.10, 9,000 shares at $90.62, and 14,000 shares at $157.13 of NHC common stock, with expiration dates from 2028 through 2031.

Does the Form 4 state how many NHC shares McCreary owns after the sales?

The filing includes a footnote indicating the total amount of shares beneficially owned following the reported transactions, but the specific post-transaction share count is not included in the structured data provided here.

What do the weighted average price footnotes mean in this NHC Form 4?

For each sale, the reported price is a weighted average of multiple trades within a stated range. The footnotes note that detailed trade-by-trade price and share information will be provided to the SEC staff, the issuer, or any NHC security holder upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 04:40 PM Accepted by SEC EDGAR 09/14/2026 - 04:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCreary Josh A

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TENNESSEE 37130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP & General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/10/2026		S		571	D	$222.7342(1)	12,127	D
Common Stock	09/10/2026		S		789	D	$223.778(2)	11,338	D
Common Stock	09/10/2026		S		1,291	D	$225.087(3)	10,047	D
Common Stock	09/10/2026		S		68	D	$225.5863(4)	9,979(5)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	4,000		4,000	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	8,000		8,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	9,000		9,000	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

1. The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.31 to $223.21, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

2. The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.35 to $224.15, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

3. The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.56 to $225.515, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

4. The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.565 to $225.60, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.

5. Total amount of shares beneficially owned following transactions reported on this form.

	/s/ Josh McCreary	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)